difference between glp 1 and compounded semaglutide Standard Dose vs Microdose GLP-1: & Tirzepatide – PlexusDx Compounded Semaglutide (GLP-1)

Orskov C, Rabenhoj L, Wettergren A, Kofod H, Holst JJ (1994) Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

A FAIR Health analysis found a nearly 600% rise in patients using GLP-1s for weight loss over six years, reaching over 2% of the population ( [2] ), even as total GLP-1 usage (for any indication) approached 4% of Americans (driven roughly half by weight-loss vs diabetes) ( [2] )

Factors That May Affect Bone Density During GLP-1 Treatment While GLP-1 medications themselves may not directly cause bone loss, several factors associated with their use warrant consideration, particularly the significant weight loss many patients experience

Clinical studies back this up, showing steady pharmacokinetic profiles with GLP-1 therapies